KAPA
Price
$1.27
Change
-$0.02 (-1.55%)
Updated
Oct 15, 11:15 AM (EDT)
Capitalization
26.76M
48 days until earnings call
Intraday Buy/Sell Signals
PHIO
Price
$2.21
Change
-$0.01 (-0.45%)
Updated
Oct 15, 11:09 AM (EDT)
Capitalization
12.54M
Intraday Buy/Sell Signals
Interact to see
Advertisement

KAPA vs PHIO

Header iconKAPA vs PHIO Comparison
Open Charts KAPA vs PHIOBanner chart's image
Kairos Pharma
Price$1.27
Change-$0.02 (-1.55%)
Volume$100
Capitalization26.76M
Phio Pharmaceuticals
Price$2.21
Change-$0.01 (-0.45%)
Volume$500
Capitalization12.54M
KAPA vs PHIO Comparison Chart in %
KAPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KAPA vs. PHIO commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAPA is a Hold and PHIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (KAPA: $1.29 vs. PHIO: $2.19)
Brand notoriety: KAPA and PHIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KAPA: 31% vs. PHIO: 44%
Market capitalization -- KAPA: $26.76M vs. PHIO: $12.54M
KAPA [@Biotechnology] is valued at $26.76M. PHIO’s [@Biotechnology] market capitalization is $12.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAPA’s FA Score shows that 0 FA rating(s) are green whilePHIO’s FA Score has 0 green FA rating(s).

  • KAPA’s FA Score: 0 green, 5 red.
  • PHIO’s FA Score: 0 green, 5 red.
According to our system of comparison, both KAPA and PHIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAPA’s TA Score shows that 3 TA indicator(s) are bullish while PHIO’s TA Score has 4 bullish TA indicator(s).

  • KAPA’s TA Score: 3 bullish, 7 bearish.
  • PHIO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than KAPA.

Price Growth

KAPA (@Biotechnology) experienced а +5.74% price change this week, while PHIO (@Biotechnology) price change was -6.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

KAPA is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KAPA($26.8M) has a higher market cap than PHIO($12.5M). PHIO YTD gains are higher at: 21.667 vs. KAPA (-15.132). KAPA has higher annual earnings (EBITDA): -4.42M vs. PHIO (-7.45M). PHIO has more cash in the bank: 10.8M vs. KAPA (3.03M). PHIO has less debt than KAPA: PHIO (0) vs KAPA (142K). KAPA (0) and PHIO (0) have equivalent revenues.
KAPAPHIOKAPA / PHIO
Capitalization26.8M12.5M214%
EBITDA-4.42M-7.45M59%
Gain YTD-15.13221.667-70%
P/E RatioN/A0.01-
Revenue00-
Total Cash3.03M10.8M28%
Total Debt142K0-
FUNDAMENTALS RATINGS
PHIO: Fundamental Ratings
PHIO
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
60
SEASONALITY SCORE
1..100
11

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KAPAPHIO
RSI
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 4 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
KAPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBB18.070.68
+3.88%
RBB Bancorp
CNMD44.531.13
+2.60%
CONMED Corp
LMT505.181.35
+0.27%
Lockheed Martin Corp
MKTX171.10-1.80
-1.04%
MarketAxess Holdings
BHM10.90-0.20
-1.81%
Bluerock Homes Trust

KAPA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KAPA has been loosely correlated with PHIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if KAPA jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAPA
1D Price
Change %
KAPA100%
+6.61%
PHIO - KAPA
47%
Loosely correlated
+0.46%
SLRX - KAPA
36%
Loosely correlated
+4.30%
AZTR - KAPA
35%
Loosely correlated
+8.85%
GDTC - KAPA
26%
Poorly correlated
+15.55%
BGMS - KAPA
22%
Poorly correlated
-2.52%
More

PHIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHIO has been loosely correlated with MTNB. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if PHIO jumps, then MTNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHIO
1D Price
Change %
PHIO100%
+0.46%
MTNB - PHIO
50%
Loosely correlated
+3.54%
TPST - PHIO
49%
Loosely correlated
+2.60%
AZTR - PHIO
49%
Loosely correlated
+8.85%
KAPA - PHIO
47%
Loosely correlated
+6.61%
SLRX - PHIO
41%
Loosely correlated
+4.30%
More